Results 151 to 160 of about 9,470 (201)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1981
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire +2 more sources
American Journal of Health-System Pharmacy, 1980
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
D D, Miller, D W, Love
openaire +2 more sources
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
D D, Miller, D W, Love
openaire +2 more sources
The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
Background/Objectives: Minoxidil, in addition to its vasodilatory effect, has also immunomodulatory properties that may be partially responsible for its efficacy in alopecia areata.
Michal Ordak +2 more
exaly +2 more sources
Chest, 1993
A 52-year-old man ingested 60 ml of 2 percent topical minoxidil solution resulting in severe hypotension and tachycardia. He was resuscitated with intravenously administered crystalloid solution and treated with intravenously administered dopamine, resulting in a partial hemodynamic improvement.
A R, MacMillan +2 more
openaire +2 more sources
A 52-year-old man ingested 60 ml of 2 percent topical minoxidil solution resulting in severe hypotension and tachycardia. He was resuscitated with intravenously administered crystalloid solution and treated with intravenously administered dopamine, resulting in a partial hemodynamic improvement.
A R, MacMillan +2 more
openaire +2 more sources
Annals of Internal Medicine, 1990
Excerpt To the Editors:Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1).
R, Colamarino, J J, Dubost, B, Sauvezie
openaire +2 more sources
Excerpt To the Editors:Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1).
R, Colamarino, J J, Dubost, B, Sauvezie
openaire +2 more sources
Dermatologic Clinics, 1987
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +2 more sources
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire +2 more sources

